Harvey Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-333
| Closed | -$304K | – | 77 |
|
|
2018
Q3 | $304K | Sell |
333
-1,815
| -84% | -$1.66M | 0.12% | 67 |
|
|
2018
Q2 | $1.57M | Sell |
2,148
-2,084
| -49% | -$1.53M | 0.62% | 45 |
|
|
2018
Q1 | $6.74M | Sell |
4,232
-6,389
| -60% | -$10.2M | 2.52% | 12 |
|
|
2017
Q4 | $9.51M | Sell |
10,621
-8,526
| -45% | -$7.64M | 3.45% | 5 |
|
|
2017
Q3 | $6.89M | Sell |
19,147
-70
| -0.4% | -$25.2K | 2.78% | 13 |
|
|
2017
Q2 | $5.64M | Buy |
19,217
+214
| +1% | +$62.8K | 2.42% | 19 |
|
|
2017
Q1 | $6.69M | Sell |
19,003
-3,844
| -17% | -$1.35M | 3.01% | 12 |
|
|
2016
Q4 | $4.2M | Sell |
22,847
-2,636
| -10% | -$485K | 1.96% | 19 |
|
|
2016
Q3 | $6.57M | Sell |
25,483
-9,390
| -27% | -$2.42M | 2.03% | 13 |
|
|
2016
Q2 | $7.44M | Sell |
34,873
-1,954
| -5% | -$417K | 3.73% | 9 |
|
|
2016
Q1 | $7.6M | Sell |
36,827
-3,066
| -8% | -$632K | 3.68% | 10 |
|
|
2015
Q4 | $10.1M | Sell |
39,893
-4,707
| -11% | -$1.19M | 3.98% | 4 |
|
|
2015
Q3 | $7.33M | Buy |
44,600
+3,287
| +8% | +$540K | 2.93% | 12 |
|
|
2015
Q2 | $7.37M | Buy |
41,313
+20,393
| +97% | +$3.64M | 2.49% | 12 |
|
|
2015
Q1 | $3.45M | Buy |
20,920
+6,230
| +42% | +$1.03M | 1.27% | 29 |
|
|
2014
Q4 | $3.42M | Sell |
14,690
-93
| -0.6% | -$21.6K | 1.31% | 25 |
|
|
2014
Q3 | $2.68M | Buy |
14,783
+586
| +4% | +$106K | 1.05% | 31 |
|
|
2014
Q2 | $2.73M | Buy |
14,197
+5,504
| +63% | +$1.06M | 0.98% | 31 |
|
|
2014
Q1 | $1.58M | Buy |
+8,693
| New | +$1.58M | 0.63% | 37 |
|